Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Newborn Screening Market, by Product Type
1.4.2 Asia Pacific Newborn Screening Market, by Test Type
1.4.3 Asia Pacific Newborn Screening Market, by End User
1.4.4 Asia Pacific Newborn Screening Market, by Technology
1.4.5 Asia Pacific Newborn Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Newborn Screening Market
Chapter 4. Asia Pacific Newborn Screening Market by Product Type
4.1 Asia Pacific Consumables Market by Country
4.2 Asia Pacific Instrument Market by Country
Chapter 5. Asia Pacific Newborn Screening Market by Test Type
5.1 Asia Pacific Blood Test Market by Country
5.2 Asia Pacific Hearing Screening Test Market by Country
5.3 Asia Pacific Heart screening Market by Country
Chapter 6. Asia Pacific Newborn Screening Market by End User
6.1 Asia Pacific Hospitals Market by Country
6.2 Asia Pacific Clinical Laboratories Market by Country
Chapter 7. Asia Pacific Newborn Screening Market by Technology
7.1 Asia Pacific Tandem Mass Spectrometry (TMS) Market by Country
7.2 Asia Pacific Molecular Assays Market by Country
7.3 Asia Pacific Immunoassays & Enzymatic Assays Market by Country
7.4 Asia Pacific Hearing Screen Technology Market by Country
7.5 Asia Pacific Pulse Oximetry Screening Technology Market by Country
7.6 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Newborn Screening Market by Country
8.1 China Newborn Screening Market
8.1.1 China Newborn Screening Market by Product Type
8.1.2 China Newborn Screening Market by Test Type
8.1.3 China Newborn Screening Market by End User
8.1.4 China Newborn Screening Market by Technology
8.2 Japan Newborn Screening Market
8.2.1 Japan Newborn Screening Market by Product Type
8.2.2 Japan Newborn Screening Market by Test Type
8.2.3 Japan Newborn Screening Market by End User
8.2.4 Japan Newborn Screening Market by Technology
8.3 India Newborn Screening Market
8.3.1 India Newborn Screening Market by Product Type
8.3.2 India Newborn Screening Market by Test Type
8.3.3 India Newborn Screening Market by End User
8.3.4 India Newborn Screening Market by Technology
8.4 South Korea Newborn Screening Market
8.4.1 South Korea Newborn Screening Market by Product Type
8.4.2 South Korea Newborn Screening Market by Test Type
8.4.3 South Korea Newborn Screening Market by End User
8.4.4 South Korea Newborn Screening Market by Technology
8.5 Singapore Newborn Screening Market
8.5.1 Singapore Newborn Screening Market by Product Type
8.5.2 Singapore Newborn Screening Market by Test Type
8.5.3 Singapore Newborn Screening Market by End User
8.5.4 Singapore Newborn Screening Market by Technology
8.6 Malaysia Newborn Screening Market
8.6.1 Malaysia Newborn Screening Market by Product Type
8.6.2 Malaysia Newborn Screening Market by Test Type
8.6.3 Malaysia Newborn Screening Market by End User
8.6.4 Malaysia Newborn Screening Market by Technology
8.7 Rest of Asia Pacific Newborn Screening Market
8.7.1 Rest of Asia Pacific Newborn Screening Market by Product Type
8.7.2 Rest of Asia Pacific Newborn Screening Market by Test Type
8.7.3 Rest of Asia Pacific Newborn Screening Market by End User
8.7.4 Rest of Asia Pacific Newborn Screening Market by Technology
Chapter 9. Company Profiles
9.1 General Electric (GE) Co. (GE Healthcare)
9.1.1 Company Overview
9.1.1 Financial Analysis
9.1.2 Segmental and Regional Analysis
9.1.3 Research & Development Expense
9.1.4 Recent strategies and developments:
9.1.4.1 Acquisition and Mergers:
9.1.5 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Bio-Rad laboratories, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.4 Natus Medical Incorporated
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Acquisition and Mergers:
9.5 Masimo Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.5.5.2 Approvals and Trials:
9.6 Waters Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 PerkinElmer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Approvals and Trials:
9.8 AB Sciex LLC (Danaher Corporation)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.9 Medtronic PLC (Covidien plc)
9.9.1 Company overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 SWOT Analysis
9.10. Trivitron Healthcare Pvt. Ltd.
9.10.1 Company Overview
Unique Offerings 